Structures by: Buist A. R.

Total: 28

(10,11-Dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>f</i>]azepin-5-yl)(hydroxy)methylidene]azanium chloride

C15H15N2O,Cl

Buist, Amanda R.Kennedy, Alan R.

Acta Crystallographica Section C (2016) 72, 2 155-160

a=5.4867(17)Å   b=9.8381(3)Å   c=50.3061(17)Å

α=90.00°   β=90.00°   γ=90.00°

(10,11-Dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>f</i>]azepin-5-yl)(hydroxy)methylidene]azanium chloride monohydrate

C15H15N2O,Cl,H2O

Buist, Amanda R.Kennedy, Alan R.

Acta Crystallographica Section C (2016) 72, 2 155-160

a=5.3048(3)Å   b=24.4966(14)Å   c=11.0163(6)Å

α=90.00°   β=96.731(5)°   γ=90.00°

(10,11-Dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>f</i>]azepin-5-yl)(hydroxy)methylidene]azanium bromide monohydrate

C15H15N2O,Br,H2O

Buist, Amanda R.Kennedy, Alan R.

Acta Crystallographica Section C (2016) 72, 2 155-160

a=5.4857(2)Å   b=24.5526(9)Å   c=10.9796(4)Å

α=90.00°   β=96.931(3)°   γ=90.00°

2-{[(4-Azaniumylphenyl)sulfonyl]azanidyl}pyrimidinium chloride monohydrate

C10H11N4O2S,Cl,H2O

Buist, Amanda R.Dennany, LynnKennedy, Alan R.Manzie, CraigMcPhie, KatherineWalker, Brandon

Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907

a=5.4118(4)Å   b=11.5632(8)Å   c=11.7430(8)Å

α=109.462(7)°   β=94.399(6)°   γ=102.509(7)°

2-{[(4-azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium chloride methanol hemisolvate

C10H11N4O2S,Cl,0.5(CH4O)

Buist, Amanda R.Dennany, LynnKennedy, Alan R.Manzie, CraigMcPhie, KatherineWalker, Brandon

Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907

a=5.6468(2)Å   b=11.2749(4)Å   c=11.8363(8)Å

α=64.254(5)°   β=79.361(6)°   γ=77.687(6)°

2-{[(4-Azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium bromide monohydrate

C10H11N4O2S,Br,H2O

Buist, Amanda R.Dennany, LynnKennedy, Alan R.Manzie, CraigMcPhie, KatherineWalker, Brandon

Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907

a=11.9420(3)Å   b=5.6295(2)Å   c=21.0659(6)Å

α=90.00°   β=98.380(3)°   γ=90.00°

Bis(2-{[(4-azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium) tetraiodide

2(C10H11N4O2S),I42

Buist, Amanda R.Dennany, LynnKennedy, Alan R.Manzie, CraigMcPhie, KatherineWalker, Brandon

Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907

a=5.7792(4)Å   b=12.0002(7)Å   c=12.5214(9)Å

α=61.964(7)°   β=87.745(5)°   γ=76.426(5)°

2-{[(4-Azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium tetrafluoroborate monohydrate

C10H11N4O2S,BF4,H2O

Buist, Amanda R.Dennany, LynnKennedy, Alan R.Manzie, CraigMcPhie, KatherineWalker, Brandon

Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907

a=5.85390(10)Å   b=11.3629(3)Å   c=21.2080(6)Å

α=90.00°   β=90.982(2)°   γ=90.00°

2-{[(4-Azaniumylphenyl)sulfonyl]azanidyl}pyrimidin-1-ium nitrate

C10H11N4O2S,NO3

Buist, Amanda R.Dennany, LynnKennedy, Alan R.Manzie, CraigMcPhie, KatherineWalker, Brandon

Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907

a=5.4705(4)Å   b=10.1235(7)Å   c=11.9956(8)Å

α=86.708(6)°   β=85.489(6)°   γ=74.394(7)°

4-[(Pyrimidin-2-yl)sulfamoyl]anilinium 4-hydroxybenzenesulfonate dihydrate

C10H11N4O2S,C6H5O4S,2(H2O)

Buist, Amanda R.Dennany, LynnKennedy, Alan R.Manzie, CraigMcPhie, KatherineWalker, Brandon

Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907

a=18.5872(5)Å   b=5.9733(2)Å   c=18.6850(5)Å

α=90.00°   β=104.858(3)°   γ=90.00°

4-[(Pyrimidin-2-yl)sulfamoyl]anilinium ethanesulfonate

C10H11N4O2S,C2H5O3S

Buist, Amanda R.Dennany, LynnKennedy, Alan R.Manzie, CraigMcPhie, KatherineWalker, Brandon

Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 900-907

a=5.5269(4)Å   b=34.979(3)Å   c=8.4395(6)Å

α=90.00°   β=93.102(7)°   γ=90.00°

1,3-Dimethyl-2,6-dioxo-7<i>H</i>-purin-9-ium tetrafluoroborate

C7H9N4O2,B1F4

Buist, Amanda R.Kennedy, Alan R.Manzie, Craig

Acta Crystallographica Section C (2014) 70, 2 220-224

a=13.0883(4)Å   b=6.04130(10)Å   c=14.5542(4)Å

α=90.00°   β=115.306(3)°   γ=90.00°

1,3-Dimethyl-2,6-dioxo-7<i>H</i>-purin-9-ium chloride monohydrate

C7H9N4O2,Br1,H2O1

Buist, Amanda R.Kennedy, Alan R.Manzie, Craig

Acta Crystallographica Section C (2014) 70, 2 220-224

a=14.0120(5)Å   b=6.6151(3)Å   c=11.5297(4)Å

α=90.00°   β=90.00°   γ=90.00°

1,3-Dimethyl-2,6-dioxo-7<i>H</i>-purin-9-ium chloride

C7H9N4O2,Cl1,H2O1

Buist, Amanda R.Kennedy, Alan R.Manzie, Craig

Acta Crystallographica Section C (2014) 70, 2 220-224

a=13.8664(7)Å   b=6.4623(3)Å   c=11.3634(6)Å

α=90.00°   β=90.00°   γ=90.00°

1,3-Dimethyl-2,6-dioxo-7<i>H</i>-purin-9-ium bromide monohydrate

C7H9N4O2,Cl1

Buist, Amanda R.Kennedy, Alan R.Manzie, Craig

Acta Crystallographica Section C (2014) 70, 2 220-224

a=32.081(3)Å   b=4.5028(3)Å   c=12.8256(10)Å

α=90.00°   β=103.524(9)°   γ=90.00°

C61H54IN8NaO6

C61H54IN8NaO6

Buist, Amanda R.Kennedy, Alan R.

Crystal Growth & Design (2014) 14, 12 6508

a=27.3789(19)Å   b=6.8157(2)Å   c=20.8598(14)Å

α=90.00°   β=134.626(12)°   γ=90.00°

C75H60I3N10NaO5

C75H60I3N10NaO5

Buist, Amanda R.Kennedy, Alan R.

Crystal Growth & Design (2014) 14, 12 6508

a=16.1230(6)Å   b=11.2270(4)Å   c=36.8726(16)Å

α=90.00°   β=91.165(3)°   γ=90.00°

C15H16BrN3O

C15H16BrN3O

Buist, Amanda R.Kennedy, Alan R.

Crystal Growth & Design (2014) 14, 12 6508

a=11.0877(7)Å   b=5.4381(4)Å   c=24.6630(19)Å

α=90.00°   β=101.058(7)°   γ=90.00°

C88H70Br4I2N11NaO5

C88H70Br4I2N11NaO5

Buist, Amanda R.Kennedy, Alan R.

Crystal Growth & Design (2014) 14, 12 6508

a=10.2171(5)Å   b=14.4369(6)Å   c=27.5476(12)Å

α=91.841(3)°   β=96.689(4)°   γ=90.972(4)°

C13H10ClI2N

C13H10ClI2N

Buist, Amanda R.Kennedy, Alan R.

Crystal Growth & Design (2014) 14, 12 6508

a=10.2879(4)Å   b=17.9944(4)Å   c=8.8718(3)Å

α=90.00°   β=122.427(5)°   γ=90.00°

C13H10BrI2N

C13H10BrI2N

Buist, Amanda R.Kennedy, Alan R.

Crystal Growth & Design (2014) 14, 12 6508

a=18.0581(12)Å   b=10.3454(3)Å   c=14.9699(5)Å

α=90.00°   β=90.00°   γ=90.00°

C15H13ClN2O

C15H13ClN2O

Buist, Amanda R.Kennedy, Alan R.Shankland, KennethShankland, NormanSpillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=7.6241(3)Å   b=9.5476(4)Å   c=17.8401(7)Å

α=90.00°   β=90.00°   γ=90.00°

C15H13BrN2O

C15H13BrN2O

Buist, Amanda R.Kennedy, Alan R.Shankland, KennethShankland, NormanSpillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=7.8120(2)Å   b=9.5016(3)Å   c=18.0400(7)Å

α=90.00°   β=90.00°   γ=90.00°

C15H15BrN2O2

C15H15BrN2O2

Buist, Amanda R.Kennedy, Alan R.Shankland, KennethShankland, NormanSpillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=5.0943(11)Å   b=11.110(2)Å   c=26.065(5)Å

α=90.00°   β=91.646(19)°   γ=90.00°

C15H15.5Cl0.5N2O2.5

C15H15.5Cl0.5N2O2.5

Buist, Amanda R.Kennedy, Alan R.Shankland, KennethShankland, NormanSpillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=29.4803(17)Å   b=4.9462(2)Å   c=21.6558(13)Å

α=90.00°   β=119.462(8)°   γ=90.00°

C15H13ClN2O

C15H13ClN2O

Buist, Amanda R.Kennedy, Alan R.Shankland, KennethShankland, NormanSpillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=14.1099(3)Å   b=17.4778(3)Å   c=5.3403(2)Å

α=90.00°   β=90.00°   γ=90.00°

C16H16.6Cl0.4NO2.6

C16H16.6Cl0.4NO2.6

Buist, Amanda R.Kennedy, Alan R.Shankland, KennethShankland, NormanSpillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=20.2651(9)Å   b=5.8463(3)Å   c=23.8489(9)Å

α=90.00°   β=95.724(4)°   γ=90.00°

C15H13BrN2O

C15H13BrN2O

Buist, Amanda R.Kennedy, Alan R.Shankland, KennethShankland, NormanSpillman, Mark J.

Crystal Growth & Design (2013) 13, 11 5121

a=5.3472(2)Å   b=10.3235(3)Å   c=49.6238(17)Å

α=90.00°   β=90.00°   γ=90.00°